Ref. Ares(2022)3545646 - 10/05/2022
EUROPEAN COMMISSION
Cabinet of Executive Vice-President Valdis Dombrovskis
Brussels,
2021
Virtual Meeting with EFPIA
26/11/2021
-----
MINUTES
Minutes of the meeting:
On Friday 26 November, 2021, Executive Vice President Valdis Dombrovskis met with the
European Federation of Pharmaceutical Industries and Associations (EFPIA) and some of
their members, at their proposal.
The meeting was requested to discuss the health initiatives under discussion at the WTO, the
bilateral trade negotiations (e.g. with New Zealand), as well as other sectoral strategies of the
European Commission and their possible effect on the international aspects of the European
pharmaceutical industry. All initiatives of direct concern for EFPIA and their member
companies and they argue to an alignment of the EU’s internal and external strategies. EFPIA
outlined the importance of the pharmaceuticals sector for the EU economy and health. The
Commission noted the concerns of EFPIA and shared the current state of the negotiations.
Topics: WTO and bilateral trade related issues
TRN:
EFPIA - 38526121292-88
Bayer - 3523776801-85
Sanofi - 61291462764-77
Invitation:
Briefing on: Basis (CAB DOMBROVSKIS/1293)
Participants from the European Commission
European Commission
Executive Vice President Mr. Valdis Dombrovskis
Commission européenne/Europese Commissie, 1049 Bruxelles/Brussel, BELGIQUE/BELGIË - Tel. +32 22991111
EFPIA and its members
Art. 4.1 (b)
,
EFPIA
,
Art. 4.1 (b)
Bayer Pharmaceuticals
Art. 4.1 (b)
, General Medicines, Sanofi
Art. 4.1 (b)
EFPIA
Art. 4.1 (b)
EFPIA
Commission européenne/Europese Commissie, 1049 Bruxelles/Brussel, BELGIQUE/BELGIË - Tel. +32 22991111